DECLARATION: HEDLEY REES, B. ENG., HONS., EXECUTIVE MBA: Control of product and material contamination, SARS-CoV-2 injections

More Expert Testimony, this time on Contamination Control

DECLARATION: HEDLEY REES, B. ENG., HONS., EXECUTIVE MBA: Control of product and material contamination, SARS-CoV-2 injections

Below is a Federal Declaration submitted to a team in Mississippi led by Dr John Witcher and support form my contact, Dr Janci Lindsay.

“Pursuant to 28 U.S.C. § 1746, Hedley Rees, Bridgend, United Kingdom, hereby declares:

I am over the age of 18 and fully competent to make this declaration through my education, knowledge, experience, and training, of the facts stated in this declaration.

This declaration is submitted in support of: LEGAL ACTIONS TO CONVENE A GRAND JURY AND TO PULL THE COVID-19 “VACCINES” UNDER CONSUMER PRODUCT PROTECTION STATUTES FOR LACK OF SAFETY AND EFFICACY, MISREPRESENTATION, MISBRANDING, ADULTERATION AND DEGRADATION, CAUSES.

Based on my experience, knowledge, and training as a pharmaceutical and biologics supply chain management and regulatory specialist, I explain below key aspects of the control of product and material contamination, and the potential impact of contamination on the identity, strength, quality, and purity of the SARS-CoV-2 injections:

1.      Any company involved in the manufacture of prescription drugs (drugs) must adhere to CGMP regulations as defined in the US Code of Federal Regulations, Title 21.